Sabra Health Care REIT, Inc.
Symbool: SBRA
NASDAQ
13.93
USDMarktprijs vandaag
234.1496
Koers/Winst Verhouding
-13.6793
Koers/Winst Groei Verhouding
3.22B
MRK Kapitalisatie
- 0.09%
DIV Rendement
Sabra Health Care REIT, Inc. (SBRA) Jaarrekeningen
Balans
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 140.74 | 46.7 | 49.3 | 112 | ||||||||||||||
balance-sheet.row.short-term-investments | 0 | 0 | 411.4 | 0 | ||||||||||||||
balance-sheet.row.net-receivables | 2116.51 | 496.6 | 559.3 | 537.2 | ||||||||||||||
balance-sheet.row.inventory | 172.54 | 46.7 | 411.4 | 119.8 | ||||||||||||||
balance-sheet.row.other-current-assets | -156.64 | -46.7 | -406.8 | -115.9 | ||||||||||||||
balance-sheet.row.total-current-assets | 2273.15 | 543.3 | 613.2 | 653.1 | ||||||||||||||
balance-sheet.row.property-plant-equipment-net | 18780.81 | 4628.9 | 4959.3 | 5162.9 | ||||||||||||||
balance-sheet.row.goodwill | 0 | 0 | 0 | 0 | ||||||||||||||
balance-sheet.row.intangible-assets | 139 | 30.9 | 40.1 | 54.1 | ||||||||||||||
balance-sheet.row.goodwill-and-intangible-assets | 139 | 30.9 | 40.1 | 54.1 | ||||||||||||||
balance-sheet.row.long-term-investments | 684.9 | 213.6 | 135 | 96.7 | ||||||||||||||
balance-sheet.row.tax-assets | -18780.81 | -4628.9 | -4959.3 | -5162.9 | ||||||||||||||
balance-sheet.row.other-non-current-assets | 18750.3 | 4598.3 | 4959.3 | 5162.9 | ||||||||||||||
balance-sheet.row.total-non-current-assets | 19574.21 | 4842.9 | 5134.4 | 5313.6 | ||||||||||||||
balance-sheet.row.other-assets | 0 | 0 | 0 | 0 | ||||||||||||||
balance-sheet.row.total-assets | 21847.35 | 5386.1 | 5747.7 | 5966.7 | ||||||||||||||
balance-sheet.row.account-payables | 121.86 | 0 | 142.3 | 143 | ||||||||||||||
balance-sheet.row.short-term-debt | 2082.36 | 196.6 | 197 | 1783.3 | ||||||||||||||
balance-sheet.row.tax-payables | 0 | 0 | 0 | 0 | ||||||||||||||
balance-sheet.row.long-term-debt-total | 9271.41 | 2217.5 | 2506.8 | 2394.5 | ||||||||||||||
Deferred Revenue Non Current | 0 | 0 | 0 | 0 | ||||||||||||||
balance-sheet.row.deferred-tax-liabilities-non-current | 0 | - | - | - | ||||||||||||||
balance-sheet.row.other-current-liab | -1467.72 | 34.8 | -197 | -1783.3 | ||||||||||||||
balance-sheet.row.total-non-current-liabilities | 9519.49 | 2352.2 | 2549 | 2444.2 | ||||||||||||||
balance-sheet.row.other-liabilities | 0 | 0 | 0 | 0 | ||||||||||||||
balance-sheet.row.capital-lease-obligations | 145.87 | 32.5 | 42.2 | 49.7 | ||||||||||||||
balance-sheet.row.total-liab | 10256 | 2583.6 | 2691.3 | 2587.2 | ||||||||||||||
balance-sheet.row.preferred-stock | 1685.51 | 20.5 | 0 | 0 | ||||||||||||||
balance-sheet.row.common-stock | 9.25 | 2.3 | 2.3 | 2.3 | ||||||||||||||
balance-sheet.row.retained-earnings | -6494.47 | -1718.3 | -1451.9 | -1095.2 | ||||||||||||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | 90.31 | 1 | 19.1 | -10 | ||||||||||||||
balance-sheet.row.other-total-stockholders-equity | 16300.75 | 4497.1 | 4487 | 4482.5 | ||||||||||||||
balance-sheet.row.total-stockholders-equity | 11591.36 | 2802.5 | 3056.4 | 3379.5 | ||||||||||||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 21847.35 | 5386.1 | 5747.7 | 5966.7 | ||||||||||||||
balance-sheet.row.minority-interest | 0 | 0 | 0 | 0 | ||||||||||||||
balance-sheet.row.total-equity | 11591.36 | 2802.5 | 3056.4 | 3379.5 | ||||||||||||||
balance-sheet.row.total-liabilities-and-total-equity | 21847.35 | - | - | - | ||||||||||||||
Total Investments | 684.9 | 213.6 | 597.4 | 96.7 | ||||||||||||||
balance-sheet.row.total-debt | 9612.77 | 2446.6 | 2703.8 | 2394.5 | ||||||||||||||
balance-sheet.row.net-debt | 9472.03 | 2399.9 | 2654.4 | 2282.5 |
Kasstroomoverzicht
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | 13.76 | 13.8 | -77.6 | -113.3 | ||||||||||||||
cash-flows.row.depreciation-and-amortization | 183.09 | 183.1 | 187.8 | 179 | ||||||||||||||
cash-flows.row.deferred-income-tax | -25.1 | 2.7 | 0 | 227.8 | ||||||||||||||
cash-flows.row.stock-based-compensation | 7.92 | 7.9 | 7.5 | 7.9 | ||||||||||||||
cash-flows.row.change-in-working-capital | -2.73 | -2.7 | -19.7 | 22.7 | ||||||||||||||
cash-flows.row.account-receivables | -11.08 | -11.1 | -6.4 | 8.2 | ||||||||||||||
cash-flows.row.inventory | -8.43 | 11.1 | 6.4 | -8.2 | ||||||||||||||
cash-flows.row.account-payables | 8.34 | 8.3 | -13.3 | 14.5 | ||||||||||||||
cash-flows.row.other-working-capital | 17.05 | -11.1 | -6.4 | 8.2 | ||||||||||||||
cash-flows.row.other-non-cash-items | 123.64 | 96.4 | 217.8 | 32.2 | ||||||||||||||
cash-flows.row.net-cash-provided-by-operating-activities | 300.57 | 0 | 0 | 0 | ||||||||||||||
cash-flows.row.investments-in-property-plant-an-equipment | -96.62 | 5.2 | 0 | -33.6 | ||||||||||||||
cash-flows.row.acquisitions-net | -6.67 | -5.2 | -142.9 | -7.8 | ||||||||||||||
cash-flows.row.purchases-of-investments | -73.23 | -191.1 | -8 | -9.1 | ||||||||||||||
cash-flows.row.sales-maturities-of-investments | 78.46 | 262.4 | 5.4 | 1.3 | ||||||||||||||
cash-flows.row.other-investing-activites | 201.18 | 31.3 | -70.7 | -287.1 | ||||||||||||||
cash-flows.row.net-cash-used-for-investing-activites | 103.13 | 102.6 | -216.2 | -336.2 | ||||||||||||||
cash-flows.row.debt-repayment | -297.87 | -112.3 | -81.3 | -767.7 | ||||||||||||||
cash-flows.row.common-stock-issued | -1.49 | -2.7 | -4.8 | 308.7 | ||||||||||||||
cash-flows.row.common-stock-repurchased | -2.68 | -2.7 | -4.8 | -308.7 | ||||||||||||||
cash-flows.row.dividends-paid | -277.45 | -277.4 | -277.2 | -262.9 | ||||||||||||||
cash-flows.row.other-financing-activites | 169.19 | -15.2 | 206.3 | 1060.7 | ||||||||||||||
cash-flows.row.net-cash-used-provided-by-financing-activities | -410.3 | -410.3 | -161.7 | 30.1 | ||||||||||||||
cash-flows.row.effect-of-forex-changes-on-cash | -0.61 | -0.6 | 0.3 | 0 | ||||||||||||||
cash-flows.row.net-change-in-cash | -7.21 | -7.2 | -62 | 50.4 | ||||||||||||||
cash-flows.row.cash-at-end-of-period | 156.64 | 46.7 | 53.9 | 115.9 | ||||||||||||||
cash-flows.row.cash-at-beginning-of-period | 163.85 | 53.9 | 115.9 | 65.5 | ||||||||||||||
cash-flows.row.operating-cash-flow | 300.57 | 301.1 | 315.7 | 356.4 | ||||||||||||||
cash-flows.row.capital-expenditure | -96.62 | 5.2 | 0 | -33.6 | ||||||||||||||
cash-flows.row.free-cash-flow | 203.95 | 306.4 | 315.7 | 322.8 |
Rij winst-en-verliesrekening
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 648.5 | 655.8 | 624.8 | 569.5 | ||||||||||||||
income-statement-row.row.cost-of-revenue | 238.12 | 378.3 | 162.6 | 141.2 | ||||||||||||||
income-statement-row.row.gross-profit | 410.38 | 277.5 | 462.2 | 428.3 | ||||||||||||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | ||||||||||||||
income-statement-row.row.research-development | 0 | - | - | - | ||||||||||||||
income-statement-row.row.selling-general-administrative | 47.47 | - | - | - | ||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | ||||||||||||||
income-statement-row.row.other-expenses | 43.2 | -42.4 | 187.9 | 182.9 | ||||||||||||||
income-statement-row.row.operating-expenses | 173.24 | 42.4 | 227.5 | 217.6 | ||||||||||||||
income-statement-row.row.cost-and-expenses | 411.36 | 420.8 | 390.1 | 358.8 | ||||||||||||||
income-statement-row.row.interest-income | 85.02 | 0 | 105.6 | 98.7 | ||||||||||||||
income-statement-row.row.interest-expense | 128.56 | 134.4 | 105.5 | 98.6 | ||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | ||||||||||||||
income-statement-row.row.total-other-income-expensenet | -164.4 | -227.2 | -211.9 | -130.5 | ||||||||||||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | ||||||||||||||
income-statement-row.row.other-operating-expenses | 43.2 | -42.4 | 187.9 | 182.9 | ||||||||||||||
income-statement-row.row.total-operating-expenses | -164.4 | -227.2 | -211.9 | -130.5 | ||||||||||||||
income-statement-row.row.interest-expense | 128.56 | 134.4 | 105.5 | 98.6 | ||||||||||||||
income-statement-row.row.depreciation-and-amortization | 183.09 | 183.1 | 187.8 | 179 | ||||||||||||||
income-statement-row.row.ebitda-caps | 420.66 | - | - | - | ||||||||||||||
income-statement-row.row.operating-income | 326.36 | 235.1 | 135.6 | 19 | ||||||||||||||
income-statement-row.row.income-before-tax | 15.76 | 7.8 | -76.4 | -111.4 | ||||||||||||||
income-statement-row.row.income-tax-expense | 2 | 2 | 1.2 | 1.8 | ||||||||||||||
income-statement-row.row.net-income | 13.76 | 13.8 | -77.6 | -113.3 |
Vaak gestelde vragen
Wat is Sabra Health Care REIT, Inc. (SBRA) totale activa?
Sabra Health Care REIT, Inc. (SBRA) totale activa is 5386150000.000.
Wat is de jaarlijkse omzet van de onderneming?
De jaarlijkse omzet is 326008000.000.
Wat is de winstmarge van de onderneming?
De bedrijfswinstmarge is 0.633.
Wat is vrije kasstroom van de onderneming?
De vrije kasstroom is {free_cash_flow}}.
Wat is de nettowinstmarge van de onderneming?
De nettowinstmarge is 0.021.
Wat is de totale omzet van de onderneming?
De totale opbrengst is 0.503.
Wat is Sabra Health Care REIT, Inc. (SBRA) nettowinst (netto-inkomen)?
De nettowinst is 13756000.000.
Wat is de totale schuld van het bedrijf?
De totale schuld is 2446635000.000.
Wat zijn de bedrijfskosten?
De bedrijfsuitgaven zijn 42446000.000.
Wat is het kasstroomcijfer van het bedrijf?
Enretprise cash is 46719000.000.